Publications by authors named "Edith Dieleman"

Claim this Profile
B
Bevacizumab for symptomatic cerebral radiation necrosis after radiation of high-grade glioma or brain metastases - when and for whom?
Lente L Kroon, Edith M T Dieleman, Vera C Keil, Marit van Barreveld, Marcel G W Dijkgraaf

Neurooncol Pract· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.
Saskia A Cooke, José S A Belderbos, Barbara Stam, Bart Reymen, Maarten Lambrecht, Edith M T Dieleman

Int J Radiat Oncol Biol Phys· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive Mechanical Ventilation Is a Promising Way to Improve Lung Cancer Radiation Therapy.
Johannes K Veldman-Landegent, Zdenko van Kesteren, Mike J Parkes, Markus F Stevens, Joost G van den Aardweg, Edith M T Dieleman

Adv Radiat Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of HA-PCI on self-reported cognitive functioning and brain metastases in small-cell lung cancer: Pooled findings of NCT01780675 and PREMER trials.
Haiyan Zeng, Sanne B Schagen, Lizza E L Hendriks, Gonzalo Sánchez-Benavides, Jaap P M Jaspers, Edith M T Dieleman

Lung Cancer· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported outcomes after personalised dose-escalation for stage II-III non-small-cell lung cancer patients: Results from the randomised ARTFORCE PET-Boost trial.
Saskia A Cooke, José S A Belderbos, Bart Reymen, Maarten Lambrecht, Gitte Fredberg Persson, Edith M T Dieleman

Radiother Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic endoscopic staging of mediastinum to guide radiotherapy planning in patients with locally advanced non-small-cell lung cancer (SEISMIC): an international, multicentre, single-arm, clinical trial.
Daniel P Steinfort, Gargi Kothari, Neil Wallace, Nicholas Hardcastle, Kanishka Rangamuwa, Edith M T Dieleman

Lancet Respir Med· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereotactic arrhythmia radioablation: A multicenter pre-post intervention safety evaluation of the implantable cardioverter-defibrillator function.
Martijn H van der Ree, Wiert F Hoeksema, Adrian Luca, Jorrit Visser, Brian V Balgobind, Edith M Dieleman

Radiother Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining critical structure contouring in STereotactic Arrhythmia Radioablation (STAR): Benchmark results and consensus guidelines from the STOPSTORM.eu consortium.
Brian V Balgobind, Jorrit Visser, Melanie Grehn, Marianne Marquard Knap, Dirk de Ruysscher, Edith M T Dieleman

Radiother Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
F-FDG-PET guided vs whole tumour radiotherapy dose escalation in patients with locally advanced non-small cell lung cancer (PET-Boost): Results from a randomised clinical trial.
Saskia A Cooke, Dirk de Ruysscher, Bart Reymen, Maarten Lambrecht, Gitte Fredberg Persson, Edith M T Dieleman

Radiother Oncol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Dutch Lung Cancer Audit-Radiotherapy (DLCA-R): Real-World Data on Stage III Non-Small Cell Lung Cancer Patients Treated With Curative Chemoradiation.
Edith Dieleman, Lisa van der Woude, Rob van Os, Liselotte van Bockel, Ida Coremans

Clin Lung Cancer· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-invasive stereotactic arrhythmia radiotherapy for ventricular tachycardia: results of the prospective STARNL-1 trial.
Martijn H van der Ree, Edith M T Dieleman, Jorrit Visser, R Nils Planken, S Matthijs Boekholdt

Europace· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose-dependent cardiac effects of collateral cardiac irradiation: Echocardiographic strain analysis in patients treated for extracardiac malignancies.
Martijn H van der Ree, Rianne H A de Bruin-Bon, Brian V Balgobind, Wiert F Hoeksema, Jorrit Visser, Edith M T Dieleman

Heart Rhythm· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct Clinical Effects of Cardiac Radioablation in the Treatment of a Patient With Therapy-Refractory Ventricular Tachycardia Storm.
Martijn H van der Ree, Edith M T Dieleman, Jorrit Visser, Judit A Adam, Rianne H A de Bruin-Bon

Adv Radiat Oncol· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality of life among patients with 4 to 10 brain metastases after treatment with whole-brain radiotherapy vs. stereotactic radiotherapy: a phase III, randomized, Dutch multicenter trial.
Dianne Hartgerink, Anna Bruynzeel, Danielle Eekers, Ans Swinnen, Coen Hurkmans, Edith Dieleman

Ann Palliat Med· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Standardizing the Cardiac Radioablation Targeting Workflow: Enabling Semi-Automated Angulation and Segmentation of the Heart According to the American Heart Association Segmented Model.
Martijn H van der Ree, Jorrit Visser, R Nils Planken, Edith M T Dieleman, S Matthijs Boekholdt

Adv Radiat Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reaction on the Interpretation of the Hippocampus Avoidance Prophylactic Cranial Irradiation Trial in SCLC (NCT01780675).
José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, Friederike Koppe, Maarten L F Lambrecht, Edith M T Dieleman

J Thorac Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why Did the Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC Not Reveal a Difference?
José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, Friederike Koppe, Maarten L F Lambrecht, Edith M T Dieleman

J Thorac Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 3 Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampus Avoidance in SCLC (NCT01780675).
José S A Belderbos, Dirk K M De Ruysscher, Katrien De Jaeger, Friederike Koppe, Maarten L F Lambrecht, Edith M T Dieleman

J Thorac Oncol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4-10 brain metastases.
Dianne Hartgerink, Anna Bruynzeel, Danielle Eekers, Ans Swinnen, Coen Hurkmans, Edith Dieleman

Neurooncol Adv· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiac radioablation-A systematic review.
Martijn H van der Ree, Oliver Blanck, Jacqueline Limpens, Charlie H Lee, Brian V Balgobind, Edith M T Dieleman

Heart Rhythm· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).
Judi van Diessen, Dirk De Ruysscher, Jan-Jakob Sonke, Eugène Damen, Karolina Sikorska, Edith Dieleman

Radiother Oncol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concurrent Daily Cisplatin and High-Dose Radiation Therapy in Patients With Stage III Non-Small Cell Lung Cancer.
Edith M T Dieleman, Apollonia L J Uitterhoeve, Meike W van Hoek, Rob M van Os, Jan Wiersma

Int J Radiat Oncol Biol Phys· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy.
Krista C J Wink, José S A Belderbos, Edith M T Dieleman, Maddalena Rossi, Coen R N Rasch

Radiother Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with locally advanced non-small cell lung cancer receiving concurrent hypofractionated chemoradiotherapy with or without cetuximab.
Iris Walraven, Michel van den Heuvel, Judi van Diessen, Eva Schaake, Wilma Uyterlinde, Edith Dieleman

Radiother Oncol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Additional weekly Cetuximab to concurrent chemoradiotherapy in locally advanced non-small cell lung carcinoma: efficacy and safety outcomes of a randomized, multi-center phase II study investigating.
Michel M van den Heuvel, Wilma Uyterlinde, Andrew D Vincent, Jeroen de Jong, Joachim Aerts, Edith Dieleman

Radiother Oncol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis